我们采用了广泛的研究方法。我们拥有基础研究和转化研究方面的专家，他们使用前沿的分子生物学，细胞生物学和微生物学技术。我们使用一系列现代技术对人体组织进行离体研究。我们拥有进行基于患者的详细生理，治疗和影像学研究的设施。我们执行本地临床试验，并协调国家和国际多中心研究。最后，我们拥有领先的胃肠道流行病学部门，为我们的研究方法增添了独特的视角。研究兴趣几乎囊括了胃肠道临床研究。我们有一个领先的疗法计划，最近的重点是开发安全的非甾体抗炎药以及这些及相关化合物的化学治疗潜力。我们在炎症性肠病方面有大型的基础和临床
We employ a broad range of research methodologies. We have experts in basic and translational research who use cutting-edge molecular biological, cell biological and microbiological techniques. We perform ex vivo research on human tissue using a range of modern technologies. We have facilities for detailed patient-based physiological, therapeutic and imaging research. We perform local clinical trials and co-ordinate national and international multi-centre studies. Finally we have a leading GI epidemiology unit which adds a unique angle to our research approach. Research interests incorporate virtually all of GI clinical research. We have a leading therapeutics programme, focussing recently on development of safe non-steroidal anti-inflammatory drugs and on the chemotherapeutic potential of these and related compounds. We have a large basic and clinical research programme in inflammatory bowel disease. Neurogastroenterology is a major interest, particularly the genesis of symptoms in irritable bowel syndrome and the development of new diagnostics and treatments.